Ascendis Pharma
ASND
ASND
132 hedge funds and large institutions have $5.49B invested in Ascendis Pharma in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 42 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 138 → 132 (-6)
16% less funds holding in top 10
Funds holding in top 10: 19 → 16 (-3)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
Holders
132
Holding in Top 10
16
Calls
$109M
Puts
$29.5M
Top Buyers
| 1 | +$289M | |
| 2 | +$106M | |
| 3 | +$53.2M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$32.8M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$25.3M |
Top Sellers
| 1 | -$73.7M | |
| 2 | -$42.5M | |
| 3 | -$33.1M | |
| 4 |
Millennium Management
New York
|
-$30.1M |
| 5 |
D.E. Shaw & Co
New York
|
-$27.8M |